157 days ago
In the 2023 half year report published in September of that year Optibiotix (OPTI) boasted that “The Board took decisive action in December 2022 and in H1 2023 to reduce Board, management and advisory costs in order to ensure each part of the business and subsequently the Group achieve operational profitability as soon as possible.” Specifically we were told that director pay for 2023 was cut by 20%. We learned that by RNS.
